129 related articles for article (PubMed ID: 18445485)
1. Knockdown of cytosolic 5'-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells.
Careddu MG; Allegrini S; Pesi R; Camici M; Garcia-Gil M; Tozzi MG
Biochim Biophys Acta; 2008 Aug; 1783(8):1529-35. PubMed ID: 18445485
[TBL] [Abstract][Full Text] [Related]
2. Initial studies to define the physiologic role of cN-II.
Filoni DN; Pesi R; Careddu MG; Camici M; Allegrini S; Collavoli A; Scarfone I; Zucchi F; Galli A; Tozzi MG
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1155-60. PubMed ID: 22132970
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II.
Cividini F; Cros-Perrial E; Pesi R; Machon C; Allegrini S; Camici M; Dumontet C; Jordheim LP; Tozzi MG
Int J Biochem Cell Biol; 2015 Aug; 65():222-9. PubMed ID: 26079827
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic 5'-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation.
Pesi R; Petrotto E; Colombaioni L; Allegrini S; Garcia-Gil M; Camici M; Jordheim LP; Tozzi MG
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037008
[TBL] [Abstract][Full Text] [Related]
5. Stably transfected adherent cancer cell models with decreased expression of 5'-nucleotidase cN-II.
Bricard G; Cros-Perrial E; Machon C; Dumontet C; Jordheim LP
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):604-612. PubMed ID: 27906612
[TBL] [Abstract][Full Text] [Related]
6. IMP-GMP specific cytosolic 5'-nucleotidase regulates nucleotide pool and prodrug metabolism.
Cividini F; Filoni DN; Pesi R; Allegrini S; Camici M; Tozzi MG
Biochim Biophys Acta; 2015 Jul; 1850(7):1354-61. PubMed ID: 25857773
[TBL] [Abstract][Full Text] [Related]
7. Determination of the enzymatic activity of cytosolic 5'-nucleotidase cN-II in cancer cells: development of a simple analytical method and related cell line models.
Jordheim LP; Puy JY; Cros-Perrial E; Peyrottes S; Lefebvre I; Périgaud C; Dumontet C
Anal Bioanal Chem; 2015 Jul; 407(19):5747-58. PubMed ID: 25998135
[TBL] [Abstract][Full Text] [Related]
8. On the physiological role of cytosolic 5'-nucleotidase II (cN-II): pathological and therapeutical implications.
Tozzi MG; Pesi R; Allegrini S
Curr Med Chem; 2013; 20(34):4285-91. PubMed ID: 23992310
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening.
Jordheim LP; Marton Z; Rhimi M; Cros-Perrial E; Lionne C; Peyrottes S; Dumontet C; Aghajari N; Chaloin L
Biochem Pharmacol; 2013 Feb; 85(4):497-506. PubMed ID: 23220537
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic properties and physiological roles of cytosolic 5'-nucleotidase II.
Itoh R
Curr Med Chem; 2013; 20(34):4260-84. PubMed ID: 23992315
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic 5'-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator.
Pesi R; Allegrini S; Balestri F; Garcia-Gil M; Cividini F; Colombaioni L; Jordheim LP; Camici M; Tozzi MG
Cells; 2021 Jan; 10(1):. PubMed ID: 33477638
[TBL] [Abstract][Full Text] [Related]
12. The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor.
Cividini F; Pesi R; Chaloin L; Allegrini S; Camici M; Cros-Perrial E; Dumontet C; Jordheim LP; Tozzi MG
Biochem Pharmacol; 2015 Mar; 94(2):63-8. PubMed ID: 25656700
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic 5'-Nucleotidase II Silencing in Lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway.
Pesi R; Allegrini S; Garcia-Gil M; Piazza L; Moschini R; Jordheim LP; Camici M; Tozzi MG
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209768
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for recombinant cytosolic 5'-nucleotidase-I and -II in AMP and IMP catabolism in COS-7 and H9c2 rat myoblast cell lines.
Sala-Newby GB; Freeman NV; Skladanowski AC; Newby AC
J Biol Chem; 2000 Apr; 275(16):11666-71. PubMed ID: 10766785
[TBL] [Abstract][Full Text] [Related]
15. Cytosolic 5'-nucleotidase II interacts with the leucin rich repeat of NLR family member Ipaf.
Cividini F; Tozzi MG; Galli A; Pesi R; Camici M; Dumontet C; Jordheim LP; Allegrini S
PLoS One; 2015; 10(3):e0121525. PubMed ID: 25811392
[TBL] [Abstract][Full Text] [Related]
16. Lead optimization and biological evaluation of fragment-based cN-II inhibitors.
Guillon R; Rahimova R; Preeti ; Egron D; Rouanet S; Dumontet C; Aghajari N; Jordheim LP; Chaloin L; Peyrottes S
Eur J Med Chem; 2019 Apr; 168():28-44. PubMed ID: 30798051
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic studies on bovine cytosolic 5'-nucleotidase II, an enzyme belonging to the HAD superfamily.
Allegrini S; Scaloni A; Careddu MG; Cuccu G; D'Ambrosio C; Pesi R; Camici M; Ferrara L; Tozzi MG
Eur J Biochem; 2004 Dec; 271(23-24):4881-91. PubMed ID: 15606776
[TBL] [Abstract][Full Text] [Related]
18. Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.
Galmarini CM; Jordheim L; Dumontet C
Leuk Lymphoma; 2003 Jul; 44(7):1105-11. PubMed ID: 12916861
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and functional consequences of cytosolic 5'-nucleotidase-IA overexpression in neonatal rat cardiomyocytes.
Sala-Newby GB; Freeman NV; Curto MA; Newby AC
Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H991-8. PubMed ID: 12750059
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.
Gallier F; Lallemand P; Meurillon M; Jordheim LP; Dumontet C; Périgaud C; Lionne C; Peyrottes S; Chaloin L
PLoS Comput Biol; 2011 Dec; 7(12):e1002295. PubMed ID: 22174667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]